Ampersand Capital Partners Closes AMP-26 at $1.5 Billion Ampersand Capital Partners, a Boston-based middle-market private equity firm dedicated to growth-oriented investments in healthcare and life sciences, has announced the closing
Ampersand Capital Partners Closes AMP-26 at $1.5 Billion Ampersand Capital Partners, a Boston-based middle-market private equity firm dedicated to growth-oriented investments in healthcare and life sciences, has announced the closing
2025 HEC Paris-DowJones Small Cap Buyout Performance Ranking Source: The 2025 HEC Paris-DowJones Small Cap Buyout Performance Ranking, published May 7, 2026, by Prof. Oliver Gottschalg, Antin IP Chaired Professor
Mouro Capital Closes Third Fund at $400 Million Mouro Capital, a specialist venture capital firm investing at the intersection of finance and technology, has announced the closing of its third
Naxicap Partners Closes NIO III Platform Naxicap Partners, a leading French private equity firm, has announced the final closing of Naxicap Investment Opportunities III (NIO III), its third-generation mid-cap investment
Eurazeo, through its Elevate team, has announced the first close of Eurazeo PME V at over €1 billion in commitments — matching the size of its previous vintage PME IV,
Water Street Healthcare Partners, a Chicago-based private equity firm dedicated exclusively to healthcare investing, has announced the first and final closing of Water Street Healthcare Partners VI, L.P. (“Fund VI”)
Capital A, a leading partner for ambitious SMEs seeking autonomous and acquisitive growth, has announced the successful closing of Capital A Fund V at €515 million in investor commitments. The
Inverness Graham, a Philadelphia-based buyout firm focused on acquiring innovative, high-growth companies where technology is transforming traditional industry, has announced the final closing of Inverness Graham Investments V (“Fund V”)
S2G Investments (S2G), a Chicago-based multi-asset investment firm focused on food & agriculture, energy, and oceans, has announced the final closing of Solutions Fund I at $1 billion — a
Intersaction, a Netherlands-based private equity firm focused on growth investments in established Dutch B2B companies, has announced the successful final closing of Intersaction Fund IV at €152 million — doubling